Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Non-Current Deferred Tax Liability: 2014-2017

Historic Non-Current Deferred Tax Liability for CytomX Therapeutics (CTMX) over the last 2 years, with Sep 2017 value amounting to $520,000.

  • CytomX Therapeutics' Non-Current Deferred Tax Liability rose 1.36% to $520,000 in Q3 2017 from the same period last year, while for Sep 2017 it was $520,000, marking a year-over-year increase of 1.36%. This contributed to the annual value of $513,000 for FY2016, which is 1.18% up from last year.
  • According to the latest figures from Q3 2017, CytomX Therapeutics' Non-Current Deferred Tax Liability is $520,000, which was down 3.53% from $539,000 recorded in Q2 2017.
  • In the past 5 years, CytomX Therapeutics' Non-Current Deferred Tax Liability registered a high of $539,000 during Q2 2017, and its lowest value of $499,000 during Q4 2014.
  • For the 3-year period, CytomX Therapeutics' Non-Current Deferred Tax Liability averaged around $515,111, with its median value being $513,000 (2016).
  • Data for CytomX Therapeutics' Non-Current Deferred Tax Liability shows a peak YoY rose of 5.07% (in 2017) over the last 5 years.
  • CytomX Therapeutics' Non-Current Deferred Tax Liability (Quarterly) stood at $499,000 in 2014, then climbed by 1.60% to $507,000 in 2015, then increased by 1.18% to $513,000 in 2016, then increased by 1.36% to $520,000 in 2017.
  • Its Non-Current Deferred Tax Liability was $520,000 in Q3 2017, compared to $539,000 in Q2 2017 and $514,000 in Q1 2017.